Westlake-Backed Arsenal Biosciences Announces $70 Million Discovery Collaboration with Bristol Myers Squibb to Advance Next-Generation T Cell Therapies for Solid Tumors
Programmable cell therapy company Arsenal Biosciences, which Westlake Village BioPartners seeded and significantly contributed to its Series A financing, today […]